This is unpublished

FDA Lifts Ban on Sending Mifepristone by Mail

January 27, 2022
Back to top

Dr. Emily Godfrey, Associate Professor of ObGyn, was recently quoted in a Prevention article about the recent FDA decision to lift its existing ban on sending Mifepristone in the mail. Dr. Godfrey stated “Mifepristone is a really important medication not only for people who are seeking pregnancy termination, but also for people who are seeking miscarriage management.”. Read the article at this link.

News Categories

Recent News

1 month 3 weeks ago
Black Maternal Health Week 2023
5 months 3 weeks ago
UW Department of Obstetrics & Gynecology issues travel w…
7 months 2 weeks ago
The Department of ObGyn celebrates World Menopause Day with…